Biocept Signs CNSide™ Licensing Agreement
VIP LIVEALERTS-PRO Biocept Signs CNSide™ Licensing Agreement Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics September 08, 2023 08:00 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) […]